Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers (original) (raw)
Baserga R (1995) The insulin-like growth factor I receptor: a key to tumour growth. Cancer Res55: 249–252 CASPubMed Google Scholar
Bernhardt G, Reile H, Birnbock H, Spruss T and Shonenberger H (1992) Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol118: 35–43 ArticleCAS Google Scholar
Blakesley VA, Stannard BS, Kalebic T, Helman LJ and LeRoith D (1997) Role of the IGF-I receptor in mutagenesis and tumour promotion. J Endocrinol152: 339–344 ArticleCAS Google Scholar
Csernus V, Schally AV and Groot K (1999) Antagonistic analogs of growth hormone-releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro. Peptides20: 843–850 ArticleCAS Google Scholar
D'Ambrosio C, Ferber A, Resnicoff M and Baserga R (1996) A soluble insulin-like growth factor I receptor that induces apoptosis of tumour cells in vivo and inhibits tumorigenesis. Cancer Res56: 4013–4020 CASPubMed Google Scholar
elAtiq F, Garrouste F, Remacle-Bonnet M, Sastre B and Pommier G (1994) Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int J Cancer57: 491–497 ArticleCAS Google Scholar
Garrouste FL, Remacle-Bonnet MM, Lehmann NM-A, Marvaldi JL and Pommier GJ (1997) Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells. Endocrinology138: 2021–2032 ArticleCAS Google Scholar
Jones JI and Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev16: 3–34 CAS Google Scholar
Kiaris H and Schally AV (1999) Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci USA96: 226–231 ArticleCAS Google Scholar
Kovacs M, Zarandi M, Halmos G, Groot K and Schally AV (1996) Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: Mechanisms of action. Endocrinol137: 5364–5369 ArticleCAS Google Scholar
Kovacs M, Schally AV, Zarandi M and Groot K (1997) Inhibition of GH release in rats by new potent antagonists of growth hormone-releasing hormone (GH-RH). Peptides18: 431–438 ArticleCAS Google Scholar
Labianca R, Pessi MA and Zamparelli G (1997) Treatment of colorectal cancer. Drugs53: 593–607 ArticleCAS Google Scholar
Lahm H, Suardet L, Laurent PL, Ficher JR, Ceyhan A, Givel J-C and Odartchenko N (1992) Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br J Cancer65: 341–346 ArticleCAS Google Scholar
Lahm H, Amstad P, Yilmaz A, Fischer JR, Givel JC, Odartchenko N and Sordat B (1996) Differential effect of interleukin-4 and transforming growth factor beta 1 on expression of proto-oncogenes and autocrine insulin-like growth factor II in colorectal carcinoma cells. Biochem Biophys Res Commun220: 334–340 ArticleCAS Google Scholar
Lamharzi N, Schally AV, Koppan M and Groot K (1998) Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II. Proc Natl Acad Sci USA95: 8864–8868 ArticleCAS Google Scholar
Lelievre V, Meunier AC, Caigneaux E, Falcon J and Muller JM (1998) Differential expression and function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines. Cell Signal10: 13–26 ArticleCAS Google Scholar
Lobie PE, Breipohl W and Waters MJ (1990) Growth hormone receptor expression in the rat gastrointestinal tract. Endocrinology126: 299–306 ArticleCAS Google Scholar
Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH and Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst91: 620–625 ArticleCAS Google Scholar
Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer65: 311–320 ArticleCAS Google Scholar
Magnusson BA, Raju RVS, Moyana TN and Sharma RK (1995) Increased N-myristoyl-transferase activity observed in rat and human colonic tumours. J Natl Cancer Inst87: 1630–1635 Article Google Scholar
Mayo KE (1992) Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Molec Endocrin6: 1734–1744 CAS Google Scholar
Michell NP, Langman MJS and Eggo MC (1997) Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Brit J Cancer76: 60–66 ArticleCAS Google Scholar
Mohan S and Baylink DJ (1996) Editorial: Insulin-like growth factor (IGF)-binding proteins in serum – do they have additional roles besides modulating the endocrine IGF actions?. J Clin Endocrinol Metab81: 3817–3820 ArticleCAS Google Scholar
Munson PJ and Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem107: 220–239 ArticleCAS Google Scholar
Orme SM, McNally RJQ, Cartwright RA and Belchetz PE (1998) Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab83: 2730–2734 CASPubMed Google Scholar
Pinski J, Schally AV, Groot K, Halmos G, Szepeshazi K, Zarandi M and Armatis P (1995) Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst87: 1787–1794 ArticleCAS Google Scholar
Pollak MN and Schally AV (1998) Mechanism of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med217: 143–152 ArticleCAS Google Scholar
Pollak MN, Perdue JF, Margolese RG, Baer K and Richard M (1987) Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett38: 223–230 ArticleCAS Google Scholar
Pollak M, Polychronakos C and Guyda H (1989) Somatostatin analogue SMS 201–995 reduces serum IGF-I levels in patients with neoplasms potentially IGF-I dependent. Anticancer Research9: 889–891 CASPubMed Google Scholar
Raderer M, Kurtaran A, Hejna M, Vorbeck F, Angelberger P, Scheithauer W and Virgolini I (1998) 123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer. Br J Cancer78: 1–5 ArticleCAS Google Scholar
Reubi JC (1995) In vitro identification of vasoactive intestinal peptide receptors in human tumours: implications for tumour imaging. J Nucl Med36: 1846–1853 CASPubMed Google Scholar
Schally AV (1994) Hypothalamic hormones: from neuroendocrinology to cancer therapy. Anti-Cancer Drugs5: 115–130 ArticleCAS Google Scholar
Schally AV, Kovacs M, Toth K and Comaru-Schally AM (1998) Antagonistic analogs of growth hormone-releasing hormone (GH-RH): endocrine and oncological studies. In: Bercu BB, Walker RF, eds. Growth hormone secretagogues in clinical practice, New York: Marcel Dekker; 145–162 Google Scholar
Singh P and Rubin N (1993) Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology105: 1218–1237 ArticleCAS Google Scholar
Singleton JR, Randolph AE and Feldman EL (1996) Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res56: 4522–4529 CASPubMed Google Scholar
Szepeshazi K, Korkut E and Schally AV (1991) Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone. Am J Pathol138: 1273–1277 CASPubMedPubMed Central Google Scholar
Toretsky JA and Helman LJ (1996) Involvement of IGF-II in human cancer. J Endocrinol149: 367–372 ArticleCAS Google Scholar
Tricoli JV, Rall LB, Karakousis CP, Herera L, Petrelli NJ, Bell GI and Shows TB (1986) Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res46: 6169–6173 CASPubMed Google Scholar
Varga JL, Schally AV, Csernus VJ, Zarandi M, Halmos G, Groot K and Rekasi Z (1999) Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. Proc Natl Acad Sci (USA)96: 692–697 ArticleCAS Google Scholar
Westley BR and May FEB (1995) Insulin-like growth factors: the unrecognised oncogenes. Br J Cancer72: 1065–1066 ArticleCAS Google Scholar
Williams NN, Gyorfi T, Iliopoulos D, Herlyn D, Greenstein D, Linnenbach AJ, Daly JM, Jensen P, Rodeck U and Herlyn M (1992) Growth-factor-independence and invasive properties of colorectal carcinoma cells. Int J Cancer50: 274–280 ArticleCAS Google Scholar
Zarandi M, Horvath JE, Halmos G, Pinski J, Nagy A, Groot K, Rekasi Z and Schally AV (1994) Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA91: 12298–12301 ArticleCAS Google Scholar
Zarandi M, Kovacs M, Horvath JE, Toth K, Halmos G, Groot K, Nagy A, Kele Z and Schally AV (1997) Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH). Peptides18: 423–430 ArticleCAS Google Scholar